Supplementary Legal Opinion of Anhui Tianhe Law Firm on the 2022 issuance of A-shares by Anhui Huaheng Biotechnology Co., Ltd. to specific targets (4)

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.